Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Minerva Neurosciences Inc (NASDAQ:NERV)

8.55
Delayed Data
As of 1:48pm ET
 +0.10 / +1.18%
Today’s Change
3.45
Today|||52-Week Range
15.84
-27.23%
Year-to-Date

Today’s Trading

Previous close8.45
Today’s open8.50
Day’s range8.25 - 8.85
Volume92,775
Average volume (3 months)170,199
Market cap$298.2M
Dividend yield--
Data as of 1:48pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)+14.66%
Earnings growth (this year)-47.98%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
CMRXChimerix Inc-0.09-1.41%
PTCTPTC Therapeutics Inc-0.16-1.83%
TTPHTetraphase Pharmaceu...-0.25-2.99%
ADXSAdvaxis Inc-0.27-3.35%
Data as of 2:08pm ET, 03/28/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$31.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rémy Luthringer
Chief Operating Officer &
Senior Vice President
Joseph Reilly
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs